Whether you live in an apartment or a house or just want to keep your home free of electromagnetic fields, there are a number of ways you can reduce exposure. One of the most straightforward is to restrict your electronic device use. It is also possible to use EMF block paint to prevent EMF radiation from entering your home. Another way to shield your house against EMF radiations is to use an RF shielding canopy. It's a kind made of net which contains EMF shielding. It's used to prevent EMFs from entering a space. Another option is to have your home equipped with a conductive enclosure. They are referred to as Faraday cages.
Numerous studies have demonstrated how the EMF that is not ionized has anti-proliferative effects on HCC cells. emf blockers behind AM RF EMF's anticancer activity in vitro is believed be based on the downregulation the cancer stem cell. This could explain the long-term response seen in patients with advanced HCC. However, the reason behind AM RF EMF's effect in patients with cancer is not evident.
emf blocker from AM electromagnetic fields (RFEM) on HCC tumor growth in vivo was studied in mice. The tumors were separated into 3 groups. First, the group that was unaffected to RF EMF. The second group was exposed RF EMF at the same frequency to that of humans. In the third, they were subjected RF EMF with HCC-specific modulation frequencies. The effects of HCCMF on tumours was evaluated against that of RCF. The results indicated that tumors treated by HCCMF had significant shrinkage. However, emf blockers treated with RCF didn't show evidence of tumour shrinkage.
The mechanism of tumour-specific AM RF EMF may be based on the fact that tumor cells require Cav3*2 T-type voltage calcium channels to promote proliferation and down-regulation. AM RF EMF's antiproliferative effect on HCC cells is controlled through CACNA1H which is a protein that is responsible for the influx of Ca2+ specific to tumours. The results indicate that CACNA1H could have more broader implications for diagnosis and treatment of various cancers.
The tumors in the control group were not exposed to RF EMF, and were fed a standard mouse diet. The tumors of HCCMF HCCMF group were treated with Huh7 cells after they were 5 to 7 weeks old. The tumours were then euthanized when they showed excessive burden.
The tumors of the three groups also showed different growth curves. The tumors treated with HCCMF saw a significant decrease in size of the tumor after 8 weeks. However, the tumors treated with RCF showed no reduction in size. The difference was highly significant. The tumours treated with RCF were able to show necrosis that is common in tumours that are exposed to RCF. The possibility is that the necrosis was due to the lack of oxygen in the larger tumours.
In summary, the results show that AM RF EMF is a powerful source of anticancer activity in vitro and in live. Numerous studies have demonstrated it is true that AM RF EMF produces measurable tumour shrinkage in HCC patients. There is a possibility that AM RF EMF produces these effects because of CACNA1H which is a protein involved in the tissue-specific Ca2+ influx. In addition, AM RF EMF may have a long-lasting influence on the development of HCC tumours in vivo.